Study of Dupilumab in pediatric patients (6-11 year-olds) for the treatment of atopic dermatitis.
Phase of Trial: Phase III
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 28 Apr 2017 According to a Sanofi media release, the company plans to initiate this trial in the third quarter of 2017.
- 28 Apr 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jul 2017, according to a Sanofi media release.
- 24 Aug 2016 New trial record